| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.088 | 0.004 |